The latest shared research on partnerships

Big Pharma + Big Pharma = Collaborative Approach to Fight Cancer

Shannon Fisher, Citeline Senior Manager, Oncology and Analytics Targeted medicines are hot.  It is no surprise that they are now “getting married”.  These couples are being created by top tier pharmaceutical companies partnering with each other for the combined development of their individual targeted drugs, offering a double-team approach to fighting cancer. This approach to drug development is different than the standard approach of “Big Pharma” in-licensing a promising drug or technology from a smaller company and developing it on their own or in conjunction with that company.   In this new experimental tactic, development is occurring on two individual drugs, each drug ...